Cargando…
SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020
OBJECTIVES: It has been suggested that ethnic minorities have been disproportionally affected by the COVID-19. We aimed to determine whether prevalence and correlates of past SARS-CoV-2 exposure varied between six ethnic groups in Amsterdam, the Netherlands. DESIGN, SETTING, PARTICIPANTS: Participan...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739540/ https://www.ncbi.nlm.nih.gov/pubmed/34992110 http://dx.doi.org/10.1136/bmjopen-2021-052752 |
_version_ | 1784629122782199808 |
---|---|
author | Coyer, Liza Boyd, Anders Schinkel, Janke Agyemang, Charles Galenkamp, Henrike Koopman, Anitra D M Leenstra, Tjalling Moll van Charante, Eric P van den Born, Bert-Jan H Lok, Anja Verhoeff, Arnoud Zwinderman, Aeilko H Jurriaans, Suzanne van Vught, Lonneke A Stronks, Karien Prins, Maria |
author_facet | Coyer, Liza Boyd, Anders Schinkel, Janke Agyemang, Charles Galenkamp, Henrike Koopman, Anitra D M Leenstra, Tjalling Moll van Charante, Eric P van den Born, Bert-Jan H Lok, Anja Verhoeff, Arnoud Zwinderman, Aeilko H Jurriaans, Suzanne van Vught, Lonneke A Stronks, Karien Prins, Maria |
author_sort | Coyer, Liza |
collection | PubMed |
description | OBJECTIVES: It has been suggested that ethnic minorities have been disproportionally affected by the COVID-19. We aimed to determine whether prevalence and correlates of past SARS-CoV-2 exposure varied between six ethnic groups in Amsterdam, the Netherlands. DESIGN, SETTING, PARTICIPANTS: Participants aged 25–79 years enrolled in the Healthy Life in an Urban Setting population-based prospective cohort (n=16 889) were randomly selected within ethnic groups and invited to participate in a cross-sectional COVID-19 seroprevalence substudy. OUTCOME MEASURES: We tested participants for SARS-CoV-2-specific antibodies and collected information on SARS-CoV-2 exposures. We estimated prevalence and correlates of SARS-CoV-2 exposure within ethnic groups using survey-weighted logistic regression adjusting for age, sex and calendar time. RESULTS: Between 24 June and 9 October 2020, we included 2497 participants. Adjusted SARS-CoV-2 seroprevalence was comparable between ethnic Dutch (24/498; 5.1%, 95% CI 2.8% to 7.4%), South-Asian Surinamese (22/451; 4.9%, 95% CI 2.2% to 7.7%), African Surinamese (22/400; 8.3%, 95% CI 3.1% to 13.6%), Turkish (30/408; 7.9%, 95% CI 4.4% to 11.4%) and Moroccan (32/391; 7.2%, 95% CI 4.2% to 10.1%) participants, but higher among Ghanaians (95/327; 26.3%, 95% CI 18.5% to 34.0%). 57.1% of SARS-CoV-2-positive participants did not suspect or were unsure of being infected, which was lowest in African Surinamese (18.2%) and highest in Ghanaians (90.5%). Correlates of SARS-CoV-2 exposure varied across ethnic groups, while the most common correlate was having a household member suspected of infection. In Ghanaians, seropositivity was associated with older age, larger household sizes, living with small children, leaving home to work and attending religious services. CONCLUSIONS: No remarkable differences in SARS-CoV-2 seroprevalence were observed between the largest ethnic groups in Amsterdam after the first wave of infections. The higher infection seroprevalence observed among Ghanaians, which passed mostly unnoticed, warrants wider prevention efforts and opportunities for non-symptom-based testing. |
format | Online Article Text |
id | pubmed-8739540 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-87395402022-01-07 SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020 Coyer, Liza Boyd, Anders Schinkel, Janke Agyemang, Charles Galenkamp, Henrike Koopman, Anitra D M Leenstra, Tjalling Moll van Charante, Eric P van den Born, Bert-Jan H Lok, Anja Verhoeff, Arnoud Zwinderman, Aeilko H Jurriaans, Suzanne van Vught, Lonneke A Stronks, Karien Prins, Maria BMJ Open Infectious Diseases OBJECTIVES: It has been suggested that ethnic minorities have been disproportionally affected by the COVID-19. We aimed to determine whether prevalence and correlates of past SARS-CoV-2 exposure varied between six ethnic groups in Amsterdam, the Netherlands. DESIGN, SETTING, PARTICIPANTS: Participants aged 25–79 years enrolled in the Healthy Life in an Urban Setting population-based prospective cohort (n=16 889) were randomly selected within ethnic groups and invited to participate in a cross-sectional COVID-19 seroprevalence substudy. OUTCOME MEASURES: We tested participants for SARS-CoV-2-specific antibodies and collected information on SARS-CoV-2 exposures. We estimated prevalence and correlates of SARS-CoV-2 exposure within ethnic groups using survey-weighted logistic regression adjusting for age, sex and calendar time. RESULTS: Between 24 June and 9 October 2020, we included 2497 participants. Adjusted SARS-CoV-2 seroprevalence was comparable between ethnic Dutch (24/498; 5.1%, 95% CI 2.8% to 7.4%), South-Asian Surinamese (22/451; 4.9%, 95% CI 2.2% to 7.7%), African Surinamese (22/400; 8.3%, 95% CI 3.1% to 13.6%), Turkish (30/408; 7.9%, 95% CI 4.4% to 11.4%) and Moroccan (32/391; 7.2%, 95% CI 4.2% to 10.1%) participants, but higher among Ghanaians (95/327; 26.3%, 95% CI 18.5% to 34.0%). 57.1% of SARS-CoV-2-positive participants did not suspect or were unsure of being infected, which was lowest in African Surinamese (18.2%) and highest in Ghanaians (90.5%). Correlates of SARS-CoV-2 exposure varied across ethnic groups, while the most common correlate was having a household member suspected of infection. In Ghanaians, seropositivity was associated with older age, larger household sizes, living with small children, leaving home to work and attending religious services. CONCLUSIONS: No remarkable differences in SARS-CoV-2 seroprevalence were observed between the largest ethnic groups in Amsterdam after the first wave of infections. The higher infection seroprevalence observed among Ghanaians, which passed mostly unnoticed, warrants wider prevention efforts and opportunities for non-symptom-based testing. BMJ Publishing Group 2022-01-06 /pmc/articles/PMC8739540/ /pubmed/34992110 http://dx.doi.org/10.1136/bmjopen-2021-052752 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Infectious Diseases Coyer, Liza Boyd, Anders Schinkel, Janke Agyemang, Charles Galenkamp, Henrike Koopman, Anitra D M Leenstra, Tjalling Moll van Charante, Eric P van den Born, Bert-Jan H Lok, Anja Verhoeff, Arnoud Zwinderman, Aeilko H Jurriaans, Suzanne van Vught, Lonneke A Stronks, Karien Prins, Maria SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020 |
title | SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020 |
title_full | SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020 |
title_fullStr | SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020 |
title_full_unstemmed | SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020 |
title_short | SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020 |
title_sort | sars-cov-2 antibody prevalence and correlates of six ethnic groups living in amsterdam, the netherlands: a population-based cross-sectional study, june–october 2020 |
topic | Infectious Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739540/ https://www.ncbi.nlm.nih.gov/pubmed/34992110 http://dx.doi.org/10.1136/bmjopen-2021-052752 |
work_keys_str_mv | AT coyerliza sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT boydanders sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT schinkeljanke sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT agyemangcharles sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT galenkamphenrike sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT koopmananitradm sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT leenstratjalling sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT mollvancharanteericp sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT vandenbornbertjanh sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT lokanja sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT verhoeffarnoud sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT zwindermanaeilkoh sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT jurriaanssuzanne sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT vanvughtlonnekea sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT stronkskarien sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 AT prinsmaria sarscov2antibodyprevalenceandcorrelatesofsixethnicgroupslivinginamsterdamthenetherlandsapopulationbasedcrosssectionalstudyjuneoctober2020 |